Skip to main content
Erschienen in:

30.05.2024 | ORIGINAL ARTICLE

Non-small cell lung carcinoma with clear cell features: a clinicopathologic, immunohistochemical, and molecular study of 31 cases

verfasst von: David I. Suster, Natali Ronen, Haider A. Mejbel, Shuko Harada, A. Craig Mackinnon, Saul Suster

Erschienen in: Virchows Archiv | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Non-small cell lung carcinoma with predominantly clear cell features is a rare histologic presentation of lung carcinoma. We have examined 31 cases of lung carcinomas showing extensive clear cell features. The patients were 10 women and 21 men aged 47–92 years (mean: 70 years). The tumors showed a predilection for the right upper and lower lobes and measured from 0.8 to 9.5 cm (mean: 4.2 cm). By immunohistochemistry, 9 cases were typed as adenocarcinoma, 19 cases as squamous cell carcinoma, and 3 showed a “null” phenotype with complete loss of markers for adenocarcinoma or squamous cell carcinoma. Most cases that typed as adenocarcinoma showed a solid growth pattern. A subset of the solid adenocarcinoma cases showed a distinctive “pseudosquamous” morphology. Next-generation sequencing was performed in 20 cases and showed a variety of molecular alterations. The most common abnormalities were found in the TP53 gene (9 cases), FGFR gene family (8 cases), KRAS (5 cases), AKT1 (5 cases), and BRAF (3 cases). Clinical follow-up was available in 21 patients; 16/21 patients died of their tumors from 6 months to 12 years after initial diagnosis (mean: 4.2 years, median: 1.5 years). Four patients were alive and well from 4 to 27 years (mean: 11.5 years, median: 7.5 years); all were pathologic stage 1 or 2. NSCLC with clear cell features can display aggressive behavior and needs to be distinguished from various other tumors of the lung that can show clear cell morphology. The identification of targetable molecular alterations in some of these tumors may be of value for therapeutic management.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat World Health Organization Classification of Tumors – 5th Edition (2021) Thoracic tumors. WHO editorial board. IARC, Lyon, France World Health Organization Classification of Tumors – 5th Edition (2021) Thoracic tumors. WHO editorial board. IARC, Lyon, France
9.
Zurück zum Zitat Suster D, Ronen N, Suster S. Pseudosquamous adenocarcinoma of the lung: clinicopathologic and immunohistochemical study of 10 cases. [Accepted for publication in Am J Surg Path] Suster D, Ronen N, Suster S. Pseudosquamous adenocarcinoma of the lung: clinicopathologic and immunohistochemical study of 10 cases. [Accepted for publication in Am J Surg Path]
10.
Zurück zum Zitat Wang R, Wang L, Li Y, Shen L, Shen X, Pan Y et al (2014) FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. Clin Cancer Res 20:4107–4114CrossRefPubMed Wang R, Wang L, Li Y, Shen L, Shen X, Pan Y et al (2014) FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. Clin Cancer Res 20:4107–4114CrossRefPubMed
11.
Zurück zum Zitat Capelleti M, Dodge ME, Ercan D, Hammerman PS, Park SI, Kim J et al (2014) Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma. Clin Cancer Res 20:6551–6558CrossRef Capelleti M, Dodge ME, Ercan D, Hammerman PS, Park SI, Kim J et al (2014) Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma. Clin Cancer Res 20:6551–6558CrossRef
12.
Zurück zum Zitat Xue J, Chen W, Xu W, Xu Z, Li X, Qi F, Wang Z (2021) Patterns of metastases in patients with clear cell renal cell carcinoma – A population-based analysis. Cancer Med 10:173–187CrossRefPubMed Xue J, Chen W, Xu W, Xu Z, Li X, Qi F, Wang Z (2021) Patterns of metastases in patients with clear cell renal cell carcinoma – A population-based analysis. Cancer Med 10:173–187CrossRefPubMed
13.
Zurück zum Zitat Wei H, Miao J, Cui J, Zheng W, Chen X, Zhang Q, Liu F, Mao Z, Qiu S, Zhang D (2021) The prognosis and clinicopathologic features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database. Sci Rep 11:17822CrossRefPubMedPubMedCentral Wei H, Miao J, Cui J, Zheng W, Chen X, Zhang Q, Liu F, Mao Z, Qiu S, Zhang D (2021) The prognosis and clinicopathologic features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database. Sci Rep 11:17822CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Tong G-X, Yu WM, Beaubier NT, Weeden EM, Hamela-Bena D, Mansukhani MM, O’Toole KM (2009) Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod Pathol 22:1218–1227CrossRefPubMed Tong G-X, Yu WM, Beaubier NT, Weeden EM, Hamela-Bena D, Mansukhani MM, O’Toole KM (2009) Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod Pathol 22:1218–1227CrossRefPubMed
15.
Zurück zum Zitat Yasir S, Herrera L, Gomez-Fernandes C, Reis IM, Umar S, Leveilee R, Kava B, Jorda M (2012) CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers. Appl Immunohistochem Mol Morphol 20:454–461CrossRefPubMed Yasir S, Herrera L, Gomez-Fernandes C, Reis IM, Umar S, Leveilee R, Kava B, Jorda M (2012) CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers. Appl Immunohistochem Mol Morphol 20:454–461CrossRefPubMed
16.
Zurück zum Zitat Mentrikoski MJ, Wendroth SM, Wick MR (2014) Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear cell histomorphology: utility of CD10 and CA-125 in addition to PAX2, PAX-8, RCCma, and adipophilin. Appl Immunohistochem Mol Morphol 22:635–641CrossRefPubMed Mentrikoski MJ, Wendroth SM, Wick MR (2014) Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear cell histomorphology: utility of CD10 and CA-125 in addition to PAX2, PAX-8, RCCma, and adipophilin. Appl Immunohistochem Mol Morphol 22:635–641CrossRefPubMed
17.
Zurück zum Zitat Kubo T, Hirohashi Y, Fujita H, Sugita S, Kikuchi Y, Shinkawa T et al (2018) Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: a case report of a diagnostic pitfall for clinicians and pathologists. Respir Med Case Rep 25:306–308PubMedPubMedCentral Kubo T, Hirohashi Y, Fujita H, Sugita S, Kikuchi Y, Shinkawa T et al (2018) Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: a case report of a diagnostic pitfall for clinicians and pathologists. Respir Med Case Rep 25:306–308PubMedPubMedCentral
18.
Zurück zum Zitat Anglesio MS, Carey MS, Kobel M, Mackay H, Huntsman DG (2011) Clear cell carcinoma of the ovary: a report from the first ovarian clear cell symposium, June 24th, 2010. Gynecol Oncol 121:407–415CrossRefPubMed Anglesio MS, Carey MS, Kobel M, Mackay H, Huntsman DG (2011) Clear cell carcinoma of the ovary: a report from the first ovarian clear cell symposium, June 24th, 2010. Gynecol Oncol 121:407–415CrossRefPubMed
19.
Zurück zum Zitat DeLair D, Oliva E, Kobel M, Macias A, Gilks CB, Soslow RA (2011) Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol 35:36–44CrossRefPubMed DeLair D, Oliva E, Kobel M, Macias A, Gilks CB, Soslow RA (2011) Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol 35:36–44CrossRefPubMed
20.
Zurück zum Zitat Yamashita Y, Nagasaka T, Naiki-Ito A, Sato S, Suzuki S, Toyokuni A, Ito M, Takahashi S (2015) Napsin A is a specific marker for ovarian clear cell adenocarcinoma. Mod Pathol 28:111–117CrossRefPubMed Yamashita Y, Nagasaka T, Naiki-Ito A, Sato S, Suzuki S, Toyokuni A, Ito M, Takahashi S (2015) Napsin A is a specific marker for ovarian clear cell adenocarcinoma. Mod Pathol 28:111–117CrossRefPubMed
21.
Zurück zum Zitat Nakatani Y, Kitamura H, Inayama Y, Kamijo S, Nagashima Y, Shimoyama K, Nakamura N, Sano J, Ogawa N, Shibagaki T, Resl M, Mark EJ (1998) Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am J Surg Pathol 22:399–411CrossRefPubMed Nakatani Y, Kitamura H, Inayama Y, Kamijo S, Nagashima Y, Shimoyama K, Nakamura N, Sano J, Ogawa N, Shibagaki T, Resl M, Mark EJ (1998) Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am J Surg Pathol 22:399–411CrossRefPubMed
22.
Zurück zum Zitat Sato S, Koike T, Yamato Y, Yoshiya K, Honma K, Tsukada H (2006) Resected well-differentiated fetal pulmonary adenocarcinoma and summary of 25 cases reported in Japan. Jpn J Thorac Cardiovasc Surg 54:539–542CrossRefPubMed Sato S, Koike T, Yamato Y, Yoshiya K, Honma K, Tsukada H (2006) Resected well-differentiated fetal pulmonary adenocarcinoma and summary of 25 cases reported in Japan. Jpn J Thorac Cardiovasc Surg 54:539–542CrossRefPubMed
23.
Zurück zum Zitat Nakatani Y, Masudo K, Miyagi Y, Inayama Y, Kawano N, Tanaka Y, Kato K, Ito T, Kitamura H, Nagashima Y, Yamanaka S, Nakamura N, Sano J, Ogawa N, Ishiwa N, Notohara K, Resl M, Mark EJ (2002) Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod Pathol 15(6):617–624. https://doi.org/10.1038/modpathol.3880575CrossRefPubMed Nakatani Y, Masudo K, Miyagi Y, Inayama Y, Kawano N, Tanaka Y, Kato K, Ito T, Kitamura H, Nagashima Y, Yamanaka S, Nakamura N, Sano J, Ogawa N, Ishiwa N, Notohara K, Resl M, Mark EJ (2002) Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod Pathol 15(6):617–624. https://​doi.​org/​10.​1038/​modpathol.​3880575CrossRefPubMed
24.
Zurück zum Zitat Thakur S, Nambirajan A, Larsen BT, Butt YM, Roden AC, Kuman S, Jain D (2023) Primary pulmonary hyalinizing clear cell carcinoma: case series with review of literature. Int J Surg Pathol 31:1187–1194CrossRefPubMed Thakur S, Nambirajan A, Larsen BT, Butt YM, Roden AC, Kuman S, Jain D (2023) Primary pulmonary hyalinizing clear cell carcinoma: case series with review of literature. Int J Surg Pathol 31:1187–1194CrossRefPubMed
25.
Zurück zum Zitat Roden AC (2021) Recent updates in salivary gland tumors of the lung. Semin Diagn Pathol 38:98–108CrossRefPubMed Roden AC (2021) Recent updates in salivary gland tumors of the lung. Semin Diagn Pathol 38:98–108CrossRefPubMed
26.
Zurück zum Zitat Takamatsu M, Sato Y, Muto M, Nagano H, Ninomiya H, Sakakibara R, Baba S, Sakata S, Tekeuchi K, Okumura S, Ishikawa Y (2018) Hyalinizing clear cell carcinoma of bronchial gland: presentation of three cases and pathologic comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinoma. Mod Pathol 31:923–933CrossRefPubMed Takamatsu M, Sato Y, Muto M, Nagano H, Ninomiya H, Sakakibara R, Baba S, Sakata S, Tekeuchi K, Okumura S, Ishikawa Y (2018) Hyalinizing clear cell carcinoma of bronchial gland: presentation of three cases and pathologic comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinoma. Mod Pathol 31:923–933CrossRefPubMed
27.
Zurück zum Zitat Gaffey MJ, Mills SE, Zarbo RJ, Ross GW, Sale GE, Kulander BG, Visscher DW, Yousem SA, Colby TV (1990) Clear cell tumor of the lung. A clinicopathologic, immunohistochemical, and ultrastructural study of 8 cases. Am J Surg Pathol 14:248–259CrossRefPubMed Gaffey MJ, Mills SE, Zarbo RJ, Ross GW, Sale GE, Kulander BG, Visscher DW, Yousem SA, Colby TV (1990) Clear cell tumor of the lung. A clinicopathologic, immunohistochemical, and ultrastructural study of 8 cases. Am J Surg Pathol 14:248–259CrossRefPubMed
28.
Zurück zum Zitat Thway K, Fisher C (2015) PEComa: morphology and genetics of a complex tumor family. Ann Diagn Pathol 19:359–368CrossRefPubMed Thway K, Fisher C (2015) PEComa: morphology and genetics of a complex tumor family. Ann Diagn Pathol 19:359–368CrossRefPubMed
29.
Zurück zum Zitat Chen YB, Guo L-C, Huang JA, Ji C, Ling CH (2014) Clear cell tumor of the lung: a retrospective analysis. Am J Med Sci 347:50–53CrossRefPubMed Chen YB, Guo L-C, Huang JA, Ji C, Ling CH (2014) Clear cell tumor of the lung: a retrospective analysis. Am J Med Sci 347:50–53CrossRefPubMed
30.
Zurück zum Zitat Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho HY, Dogan S, Ladanyi M, Martignoni G, Goldblum JR, Weiss SW (2010) A distinctive subset of PEComas harbor TFE3 gene fusions. Am J Surg Pathol 15:644–653 Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho HY, Dogan S, Ladanyi M, Martignoni G, Goldblum JR, Weiss SW (2010) A distinctive subset of PEComas harbor TFE3 gene fusions. Am J Surg Pathol 15:644–653
31.
Zurück zum Zitat Falconieri G, Mirra M, Michal M, Suster S (2013) Hemangioblastoma-like clear cell stromal tumor of lung. Adv Anat Pathol 20:130–135CrossRefPubMed Falconieri G, Mirra M, Michal M, Suster S (2013) Hemangioblastoma-like clear cell stromal tumor of lung. Adv Anat Pathol 20:130–135CrossRefPubMed
32.
Zurück zum Zitat Lindholm KE, Moran CA (2020) Hemangioblastoma-like clear cell stromal tumor of the lung: a clinicopathologic and immunohistochemical study of 5 cases. Am J Surg Pathol 44:771–775CrossRefPubMed Lindholm KE, Moran CA (2020) Hemangioblastoma-like clear cell stromal tumor of the lung: a clinicopathologic and immunohistochemical study of 5 cases. Am J Surg Pathol 44:771–775CrossRefPubMed
33.
Zurück zum Zitat Agaimy A, Stoehr R, Michal M, Christopoulos P, Winter H, Zhang L, Stenzinger A, Michal M, Mechtershwimer G, Antonescu CR (2021) Recurrent YAP1-TFE3 gene fusions in clear cell stromal tumor. Am J Surg Pathol 45:1541–1549CrossRefPubMedPubMedCentral Agaimy A, Stoehr R, Michal M, Christopoulos P, Winter H, Zhang L, Stenzinger A, Michal M, Mechtershwimer G, Antonescu CR (2021) Recurrent YAP1-TFE3 gene fusions in clear cell stromal tumor. Am J Surg Pathol 45:1541–1549CrossRefPubMedPubMedCentral
Metadaten
Titel
Non-small cell lung carcinoma with clear cell features: a clinicopathologic, immunohistochemical, and molecular study of 31 cases
verfasst von
David I. Suster
Natali Ronen
Haider A. Mejbel
Shuko Harada
A. Craig Mackinnon
Saul Suster
Publikationsdatum
30.05.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 1/2024
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-024-03833-5

Neu im Fachgebiet Pathologie

Foundation Modelle in der Pathologie

Foundation Modelle ermöglichen es, durch selbstüberwachtes Vortraining neuronale Netze auf Anwendungen in bestimmten Domänen vorzubereiten, wie beispielsweise Sprachanwendungen oder Bildanalyse. Diese können für spezifische Anwendungen wie die …

Kolonpolypen – Nomenklatur, Histologie und Molekularpathologie

Polypen sind makroskopisch sichtbare Ausstülpungen der Mukosa in Hohlorganen. Im Kolon dominieren epitheliale Neubildungen, die sich von der Mukosa ableiten. Diese lassen sich nach ihrer Morphologie in klassische und serratierte Adenome …

Besonderheiten in der Erforschung und Diagnostik seltener Erkrankungen

Molekulare Methoden haben die Diagnostik vieler seltener Tumoren verbessert, aber auch methodische Grenzen offenbart. So kommen ursprünglich spezifisch erscheinende Genfusionen „promiskuitiv“ bei unterschiedlichen mesenchymalen und epithelialen …

Molekularpathologie des nichtkleinzelligen Lungenkarzinoms: aktuelle und kommende Biomarker

  • Open Access
  • NSCLC
  • CME-Artikel

In der Klassifikation des Lungenkarzinoms gilt weiterhin die grundsätzliche Einteilung nach kleinzelligen und nichtkleinzelligen Karzinomen (NSCLC). Trotz gleicher histologischer Subtypisierung ist bekannt, dass es definierte genetische …